Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?

Core Laboratories Inc. (NYSE:CLB)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $15.60 and traded as high as $16.29. Core Laboratories shares last traded at $15.8820, with a volume of 330,035 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Core Laboratories in a report on Monday, December 29th. Four research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $12.50.

Core Laboratories Stock Performance

The company has a quick ratio of 1.57, a current ratio of 2.07 and a debt-to-equity ratio of 0.39. The stock has a fifty day moving average price of $18.35 and a two-hundred day moving average price of $15.60. The company has a market capitalization of $739.47 million, a price-to-earnings ratio of 23.70, a PEG ratio of 14.33 and a beta of 1.10.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. Core Laboratories had a return on equity of 12.09% and a net margin of 6.04%.The firm had revenue of $138.26 million during the quarter, compared to analysts’ expectations of $130.40 million. During the same quarter last year, the business posted $0.22 EPS. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. As a group, analysts forecast that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 9th. Stockholders of record on Monday, February 16th were issued a dividend of $0.01 per share. The ex-dividend date was Friday, February 13th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. Core Laboratories’s payout ratio is 5.97%.

Hedge Funds Weigh In On Core Laboratories

Several institutional investors and hedge funds have recently modified their holdings of CLB. Aster Capital Management DIFC Ltd purchased a new stake in Core Laboratories in the 4th quarter worth approximately $34,000. Quarry LP raised its holdings in Core Laboratories by 118.1% in the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after acquiring an additional 1,599 shares during the last quarter. CWM LLC lifted its stake in shares of Core Laboratories by 36.1% during the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after purchasing an additional 668 shares during the period. Hantz Financial Services Inc. lifted its stake in shares of Core Laboratories by 124.7% during the 4th quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after purchasing an additional 1,763 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of Core Laboratories by 73.3% during the fourth quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company’s stock worth $83,000 after purchasing an additional 2,181 shares during the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.